Contingency management intervention targeting co-addiction of alcohol and drugs among American Indian adults: Design,methodology,and baseline data

Abstract

Background/Aims

American Indian adults have some of the highest alcohol abstinence rates compared to the overall US population. Despite this, many American Indian people are more likely to concurrently use alcohol and illicit drugs and are less likely to participate and remain in outpatient treatment for alcohol and other drug use compared to the general US population. There is limited knowledge about effective interventions targeting alcohol and drug co-addiction among American Indian adults. Contingency management is a behavioral intervention designed to increase drug abstinence by offering monetary incentives in exchange for drug and alcohol negative urine samples. We aim to evaluate and describe a culturally tailored contingency management intervention to increase alcohol and other drug abstinence among American Indian adults residing in a Northern Plains reservation.

Methods

This 2 × 2 factorial, randomized controlled trial currently includes 114 American Indian adults with alcohol and/or drug dependence who are seeking treatment. Participants were randomized into one of four groups that received (1) contingency management for alcohol, (2) contingency management for other drug, (3) contingency management for both substances, or (4) no contingency management for either substance. We present descriptive, baseline data to characterize the sample and describe the modified contingency management approach that is specific to the community wherein this trial was being conducted.

Results

The sample is 49.1% male, with an average age of 35.8 years (standard deviation = 10.4 years). At baseline, 43.0% of the sample tested positive for ethyl glucuronide, 50.9% of participants self-reported methamphetamine as their most used drug, 36.8% self-reported cannabis, and 12.3% self-reported prescription opiates as their most used drug. Among randomized participants, 47.4% tested positive for cannabis, 28.1% tested positive for methamphetamine, 16.7% tested positive for amphetamines, and 2.1% tested positive for opiates.

Conclusion

This is the first study to examine a culturally tailored contingency management intervention targeting co-addiction of two substances among American Indian adults. By establishing a tribal–university partnership to adapt, implement, and evaluate contingency management, we will increase the literature on evidence-based addiction treatments and research, while improving trust for addiction interventions among American Indian communities through ongoing collaboration. Moreover, results have implications for the use of contingency management as an intervention for co-addiction in any population.

Keywords

Contingency management American Indians substance use disorder treatment co-addiction ethyl glucuronide randomized clinical trial

Get full access to this article

View all access options for this article.

References

Gone

Trimble

American Indian and Alaska Native mental health: diverse perspectives on enduring disparities. Annu Rev Clin Psychol 2012; 8: 131–160.

Spicer

Beals

Croy

et al . The prevalence of DSM-III-R alcohol dependence in two American Indian populations. Alcohol Clin Exp Res 2003; 27: 1785–1797.

U.S. Department of Health and Human Services. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.

Cunningham

Solomon

Muramoto

ML.

Alcohol use among Native Americans compared to whites: examining the veracity of the “Native American elevated alcohol consumption” belief. Drug Alcohol Depend 2016; 160: 65–75.

National Institutes of Health. Alcohol use and alcohol use disorders in the United States: main findings from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, 2006.

U.S. Department of Health and Human Services. Trends in Indian health. 2014 ed. Rockville, MD: Division of Program Statistics, Office of Public Health Support, Indian Health Service, U.S. Department of Health and Human Services, 2014.

Duran

Healing the soul wound: counseling with American Indian and other Native peoples. New York: Teachers College Press, 2006.

Duran

Native American postcolonial psychology. Albany, NY: State University of New York Press, 1995.

National Survey on Drug Use Health. The NSDUH report: substance use among American Indian or Alaska Native adolescents, 2011. https://www.datafiles.samhsa.gov/study-publication/substance-use-among-american-indian-or-alaska-native-adolescents-nid14977

10.

Naimi

Cobb

Boyd

et al . Alcohol-attributable deaths and years of potential life lost among American Indians and Alaska Natives—United States, 2001–2005. MMWR Morb Mortal Wkly Rep 2008; 57: 938–941.

11.

Mitchell

Beals

Novins

et al . Drug use among two American Indian populations: prevalence of lifetime use and DSM-IV substance use disorders. Drug Alcohol Depend 2003; 69: 29–41.

12.

Beals

Novins

Spicer

et al . Help seeking for substance use problems in two American Indian reservation populations. Psychiatr Serv 2006; 57: 512–520.

13.

Beals

Spicer

Mitchell

et al . Racial disparities in alcohol use: comparison of 2 American Indian reservation populations with national data. Am J Public Health 2003; 93: 1683–1685.

14.

Midanik

Tam

Weisner

Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend 2007; 90: 72–80.

15.

Center for Behavioral Health Statistics Quality. Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health (HHS Publication No. SMA 16-4984, NSDUH Series H-51). Rockville, MD: Substance Abuse and Mental Health Services Administration, 2016.

16.

Substance Abuse Mental Health Services Administration. The NSDUH report: substance use among American Indian or Alaska Native adults. Rockville, MD: Office of Applied Studies, 2010.

17.

Feldstein

Venner

May

. American Indian/Alaska Native alcohol-related incarceration and treatment. Am Indian Alaska Native Ment Health Res 2006; 13: 1–22.

18.

Callaghan

RC.

Risk factors associated with dropout and readmission among First Nations individuals admitted to an inpatient alcohol and drug detoxification program. CMAJ 2003; 169: 23–27.

19.

Greenfield

Venner

KL.

Review of substance use disorder treatment research in Indian country: future directions to strive toward health equity. Am J Drug Alcohol Abuse 2012; 38: 483–492.

20.

O’Malley

Robin

Levenson

et al . Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska Natives and non-Natives residing in rural settings: a randomized controlled trial. Alcohol Clin Exp Res 2008; 32: 1271–1283.

21.

Woodall

Delaney

Kunitz

et al . A randomized trial of a DWI intervention program for first offenders: intervention outcomes and interactions with antisocial personality disorder among a primarily American-Indian sample. Alcohol Clin Exp Res 2007; 31: 974–987.

22.

Gone

Alcantara

Identifying effective mental health interventions for American Indians and Alaska Natives: a review of the literature. Cultur Divers Ethnic Minor Psychol 2007; 13: 356–363.

23.

Nebelkopf

King

Wright

et al . Growing roots: Native American evidence-based practices. J Psychoactive Drugs 2011; 43: 263–268.

24.

McDonell

Nepom

Leickly

et al . A culturally-tailored behavioral intervention trial for alcohol use disorders in three American Indian communities: rationale, design, and methods. Contemp Clinical Trials 2016; 47: 93–100.

25.

Bigelow

Silverman

KE.

Theoretical and empirical foundations of contingency management treatments for drug abuse. In: Higgins

Silverman

(eds) Motivating behavior change among illicit-drug abusers: research on contingency management interventions. Washington, DC: American Psychological Association, 1999, pp. 15–31.

26.

Stanger

Budney

AJ.

Contingency management approaches for adolescent substance use disorders. Child Adolesc Psychiatr Clin N Am 2010; 19: 547–562.

27.

Higgins

Petry

NM.

Contingency management. Incentives for sobriety. Alcohol Res Health 1999; 23: 122–127.

28.

Murphy

McDonell

McPherson

et al . An economic evaluation of a contingency-management intervention for stimulant use among community mental health patients with serious mental illness. Drug Alcohol Depend 2015; 153: 293–299.

29.

Olmstead

Petry

NM.

The cost-effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients. Drug Alcohol Depend 2009; 102: 108–115.

30.

Olmstead

Sindelar

Easton

et al . The cost-effectiveness of four treatments for marijuana dependence. Addiction 2007; 102: 1443–1453.

31.

Olmstead

Sindelar

Petry

NM.

Clinic variation in the cost-effectiveness of contingency management. Am J Addict 2007; 16: 457–460.

32.

Olmstead

Sindelar

Petry

NM.

Cost-effectiveness of prize-based incentives for stimulant abusers in outpatient psychosocial treatment programs. Drug Alcohol Depend 2007; 87: 175–182.

33.

Budney

Stanger

Tilford

et al . Computer-assisted behavioral therapy and contingency management for cannabis use disorder. Psychol Addict Behav 2015; 29: 501–511.

34.

Kurti

Davis

Redner

et al . A review of the literature on remote monitoring technology in incentive-based interventions for health-related behavior change. Transl Issues Psychol Sci 2016; 2: 128–152.

35.

Stitzer

Bigelow

Liebson

Reinforcement of drug abstinence: a behavioral approach to drug abuse treatment. NIDA Res Monogr 1979; 25: 68–90.

36.

Higgins

Budney

Bickel

et al . Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994; 51: 568–576.

37.

Stitzer

Rand

Bigelow

et al . Contingent payment procedures for smoking reduction and cessation. J Appl Behav Anal 1986; 19: 197–202.

38.

Higgins

Stitzer

Bigelow

et al . Contingent methadone delivery: effects on illicit-opiate use. Drug Alcohol Depend 1986; 17: 311–322.

39.

Robles

Stitzer

Strain

et al . Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug Alcohol Depend 2002; 65: 179–189.

40.

Budney

Higgins

Radonovich

et al . Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000; 68: 1051–1061.

41.

Kadden

Litt

Kabela-Cormier

et al . Abstinence rates following behavioral treatments for marijuana dependence. Addict Behav 2007; 32: 1220–1236.

42.

Miller

PM.

A behavioral intervention program for chronic public drunkenness offenders. Arch Gen Psychiatry 1975; 32: 915–918.

43.

Higgins

Silverman

KE.

Motivating behavior change among illicit-drug abusers: research on contingency management interventions. Washington, DC: American Psychological Association, 1999.

44.

Roll

JM.

Contingency management: an evidence-based component of methamphetamine use disorder treatments. Addiction 2007; 102: 114–120.

45.

Dutra

Stathopoulou

Basden

et al . A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 2008; 165: 179–187.

46.

Prendergast

Podus

Finney

et al . Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006; 101: 1546–1560.

47.

Lussier

Heil

Mongeon

et al . A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006; 101: 192–203.

48.

Petry

Peirce

Stitzer

et al . Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry 2005; 62: 1148–1156.

49.

Peirce

Petry

Stitzer

et al . Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry 2006; 63: 201–208.

50.

Henggeler

Chapman

Rowland

et al . Statewide adoption and initial implementation of contingency management for substance-abusing adolescents. J Consult Clin Psychol 2008; 76: 556–567.

51.

Pilling

Strang

Gerada

Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance. BMJ 2007; 335: 203–205.

52.

Helander

Böttcher

Fehr

et al . Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcoholism 2009; 44: 55–61.

53.

Wurst

Metzger

The ethanol conjugate ethyl glucuronide is a useful marker of recent alcohol consumption. Alcoholism Clin Exp Res 2002; 26: 1114–1119.

54.

Litten

Bradley

Moss

HB.

Alcohol biomarkers in applied settings: recent advances and future research opportunities. Alcohol Clin Exp Res 2010; 34: 955–967.

55.

Helmus

Saules

Schoener

et al . Reinforcement of counseling attendance and alcohol abstinence in a community-based dual-diagnosis treatment program: a feasibility study. Psychol Addict Behav 2003; 17: 249–251.

56.

Wurst

Kempter

Metzger

et al . Ethyl glucuronide: a marker of recent alcohol consumption with clinical and forensic implications. Alcohol 2000; 20: 111–116.

57.

Wurst

Seidl

Ladewig

et al . Ethyl glucuronide: on the time course of excretion in urine during detoxification. Addict Biol 2002; 7: 427–434.

58.

Wurst

Skipper

Weinmann

Ethyl glucuronide—the direct ethanol metabolite on the threshold from science to routine use. Addiction 2003; 98(Suppl. 2): 51–161.

59.

Wurst

Tabakoff

Alling

et al . World Health Organization/International Society for Biomedical Research on Alcoholism study on state and trait markers of alcohol use and dependence: back to the future. Alcohol Clin Exp Res 2005; 29: 1268–1275.

60.

Wurst

Vogel

Jachau

et al . Ethyl glucuronide discloses recent covert alcohol use not detected by standard testing in forensic psychiatric inpatients. Alcohol Clin Exp Res 2003; 27: 471–476.

61.

Skipper

Weinmann

Thierauf

et al . Ethyl glucuronide: a biomarker to identify alcohol use by health professionals recovering from substance use disorders. Alcohol Alcoholism 2004; 39: 445–449.

62.

Kip

Spies

Neumann

et al . The usefulness of direct ethanol metabolites in assessing alcohol intake in nonintoxicated male patients in an emergency room setting. Alcohol Clin Exp Res 2008; 32: 1284–1291.

63.

Sheehan

Lecrubier

Sheehan

et al . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(Suppl. 20): 22–33, quiz 34–57.

64.

Kosten

Oliveto

Feingold

et al . Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug Alcohol Depend 2003; 70: 315–325.

65.

Oliveto

Poling

Sevarino

et al . Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug Alcohol Depend 2005; 79: 157–165.

66.

Harris

Taylor

Thielke

et al . Research Electronic Data Capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377–381.

67.

Roll

Higgins

ST.

A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug Alcohol Depend 2000; 58: 103–109.

68.

Roll

Higgins

Badger

GJ.

An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J Appl Behav Anal 1996; 29: 495–505.

69.

McDonell

Leickly

McPherson

et al . A randomized controlled trial of ethyl glucuronide-based contingency management for outpatients with co-occurring alcohol use disorders and serious mental illness. Am J Psychiatry 2017; 174: 370–377.

70.

Roll

Chudzynski

Cameron

et al . Duration effects in contingency management treatment of methamphetamine disorders. Addict Behav 2013; 38: 2455–2462.

71.

McDonell

Srebnik

Angelo

et al . Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. Am J Psychiatry 2013; 170: 94–101.

72.

Chudzynski

Roll

McPherson

et al . Reinforcement schedule effects on long-term behavior change. Psychol Rec 2015; 65: 347–353.

73.

Orr

Lederhos Smith

Finlay

et al . Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management. Behav Pharmacol 2018; 29: 462–468.

74.

Ries

Dyck

Short

et al . Outcomes of managing disability benefits among patients with substance dependence and severe mental illness. Psychiatr Serv 2004; 55: 445–447.

75.

Petry

Martin

Cooney

et al . Give them prizes and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol 2000; 68: 250–257.

76.

McDonell

Skalisky

Leickly

et al . Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug Alcohol Depend 2015; 157: 184–187.

77.

Carise

Wicks

McLellan

et al . Addiction Severity Index 5th edition—North Dakota State adaptation for use with Native Americans. Philadelphia, PA: Treatment Research Institute, University of Pennsylvania, 1998.

78.

Sobell

MB.

Alcohol Timeline FollowBack. In: Rush JA, Pincus HA and Task Force for the Handbook of Psychiatric Measures (eds) Handbook of psychiatric measures. Washington, DC: American Psychiatric Association, 2000, pp. 477–479.

79.

Barry

Weinstock

Petry

NM.

Ethnic differences in HIV risk behaviors among methadone-maintained women receiving contingency management for cocaine use disorders. Drug Alcohol Depend 2008; 98: 144–153.

80.

Darke

Hall

Heather

et al . The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS 1991; 5: 181–185.

81.

Ware

Jr Kosinski

Keller

SD.

A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220–233.

82.

Quandt

Graham

Bell

et al . Ethnic disparities in health-related quality of life among older rural adults with diabetes. Ethn Dis 2007; 17: 471–476.

83.

Higgins

Delaney

Budney

et al . A behavioral approach to achieving initial cocaine abstinence. Am J Psychiatry 1991; 148: 1218–1224.